The vaccine adjuvant monophosphoryl lipid A is a partial agonist of TLR4

被引：0
|
作者：
Haro, Veronica Mata [1 ]
Casella, Carolyn R. [1 ]
Cekic, Caglar [1 ]
Chilton, Paula M. [1 ]
Mitchell, Thomas C. [1 ]
机构：
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
来源：
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [21] Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion
    Haensler, Jean
    Probeck, Patricia
    Su, Jin
    Piras, Fabienne
    Dalencon, Francois
    Cotte, Jean-Francois
    Chambon, Veronique
    Iqbal, Shehzad M.
    Hawkins, Lynn
    Burdin, Nicolas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 486 (1-2) : 99 - 111
  • [22] Synthetic Monophosphoryl Lipid A: A promising TLR 4 ligand
    Yalamati, D
    Jiang, ZHJ
    Koganty, RR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U268 - U268
  • [23] Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A
    Enkhbaatar, Perenlei
    Nelson, Christina
    Salsbury, John R.
    Carmical, Joseph R.
    Torres, Karen E. O.
    Herndon, David
    Prough, Donald S.
    Luan, Liming
    Sherwood, Edward R.
    PLOS ONE, 2015, 10 (12):
  • [24] Glucopyranosyl Lipid a (GLA) a Toll-like Receptor 4 (TLR4) Agonist for Use As an Adjuvant in Combination with Peanut Allergen Immunotherapy
    Soos, Timothy J.
    Li, Li
    Graver, Keith
    Schiding, Joanne
    Xenos, Adrienne
    Chen, Dongling
    Fitch, Neil
    Haddad, El-Bdaoui
    Jones, Catherine
    Arendt, Christopher
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB129 - AB129
  • [25] TREATMENT WITH THE TLR4 AGONIST MONOPHOSPHORYL LIPID A PROTECTS MICE AGAINST SEVERE STAPHYLOCOCCUS AUREUS INFECTION VIA AUGMENTATION OF INNATE ANTIMICROBIAL CELL FUNCTIONS
    Bohannon, Julia K.
    Fensterheim, Benjamin A.
    Luan, Liming
    Hernandez, Antonio
    Guo, Yin
    Patil, Naeem K.
    Sherwood, Edward R.
    SHOCK, 2017, 47 (06): : 27 - 28
  • [26] Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant
    Jin, Hyunjung
    Ji, Yuhyun
    An, Jinsu
    Ha, Da Hui
    Lee, Ye-Ram
    Kim, Hye-Ji
    Lee, Choon Geun
    Jeong, Wooyeon
    Kwon, Ick Chan
    Yang, Eun Gyeong
    Kim, Ki Hun
    Lee, Chankyu
    Chung, Hak Suk
    BIOTECHNOLOGY AND BIOENGINEERING, 2024, 121 (03) : 1144 - 1162
  • [27] The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine
    Hong Liang
    David Poncet
    Emilie Seydoux
    Nicholas D. Rintala
    Milton Maciel
    Sophie Ruiz
    Mark T. Orr
    npj Vaccines, 4
  • [28] The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine
    Liang, Hong
    Poncet, David
    Seydoux, Emilie
    Rintala, Nicholas D.
    Maciel, Milton, Jr.
    Ruiz, Sophie
    Orr, Mark T.
    NPJ VACCINES, 2019, 4 (1)
  • [29] Evaluation of monophosphoryl lipid A as a vaccine adjuvant for a multivalent pneumococcal glycoconjugate vaccine in mice.
    Dermody, KM
    Mason, KW
    La Posta, VJ
    FASEB JOURNAL, 1998, 12 (04): : A612 - A612
  • [30] Adjuvant application of TLR4 agonist but not TLR2 agonist attenuates hypertension-induced cardiovascular hypertrophy and fibrosis in rats
    Yang Hongzhen
    Liu Yuying
    Cui Bing
    Cai Wenfeng
    Chen Zhirong
    Jin Wen
    Yan Jun
    Xin Bingmu
    Yuan Bin
    Hu Zhuowei
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 128 - 128
12345